TY  - JOUR
AU  - García-Delpech, Salvador
AU  - Udaondo, Patricia
AU  - Fernández-Santodomingo, Alex Samir
AU  - García-Teillard, Damian
PY  - 2022
DO  - 10.1159/000525923
SN  - 1663-2699
UR  - http://hdl.handle.net/10668/20194
T2  - Case reports in ophthalmology
AB  - The authors report the use of topical recombinant human nerve growth factor cenegermin 0.02% in 5 patients diagnosed with neurotrophic keratopathy (NK) in a real-life setting. These 5 patients affected with stage II and III NK mainly of herpetic cause...
LA  - en
KW  - Cenegermin
KW  - Neurotrophic keratopathy
KW  - Recombinant human nerve growth factor
TI  - Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up.
TY  - research article
VL  - 13
ER  -